公开(公告)号：KR1020100040583A

公开(公告)日：2010-04-20

申请号：KR1020080099783

申请日：2008-10-10

Applicant: 서울대학교산학협력단

Inventor： 김성훈 ,  최진우

IPC: G01N33/574 ,  G01N33/53 ,  G01N33/68 ,  G01N33/48

Abstract: PURPOSE: A composition for diagnosing cancer containing anti-lysyl tRNA synthetase antibody and anti-laminin receptor antibody is provided to measure presence and quantity of the synthetase and receptor and to diagnose cancer. CONSTITUTION: A composition for diagnosing cancer contains anti-lysyl tRNA synthethase antibody as an active ingredient. The composition for diagnosing cancer contains anti-KRS antibody and anti-67LR(anti-laminin receptor) as an active ingredient. Cancer is colon cancer, lung cancer, liver cancer, gastric cancer, bladder cancer, prostate cancer, cervical cancer, brain cancer, lymphatic tumor or aplastic anemia. The cancer diagnosis is cancer metastasis diagnosis. A kit for diagnosing metastasis contains anti-KRS antibody and anti 67LR.

Abstract translation: 目的：提供一种用于诊断含有抗赖氨酰基tRNA合成酶抗体和抗层粘连蛋白受体抗体的组合物，用于测定合成酶和受体的存在和数量以及诊断癌症。 构成：用于诊断癌症的组合物含有抗赖氨酰tRNA合成酶抗体作为活性成分。 用于诊断癌症的组合物含有抗KRS抗体和抗-67LR（抗层粘连蛋白受体）作为活性成分。 癌症是结肠癌，肺癌，肝癌，胃癌，膀胱癌，前列腺癌，子宫颈癌，脑癌，淋巴瘤或再生障碍性贫血。 癌症诊断是癌症转移诊断。 用于诊断转移的试剂盒含有抗KRS抗体和抗67LR。